Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
Article
Lee, Eudocia Q, Kuhn, John, Lamborn, Kathleen R et al. (2012). Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
. NEURO-ONCOLOGY, 14(12), 1511-1518. 10.1093/neuonc/nos264
Lee, Eudocia Q, Kuhn, John, Lamborn, Kathleen R et al. (2012). Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
. NEURO-ONCOLOGY, 14(12), 1511-1518. 10.1093/neuonc/nos264
Lee, Eudocia Q; Kuhn, John; Lamborn, Kathleen R; Abrey, Lauren; DeAngelis, Lisa M; Lieberman, Frank; Robins, H Ian; Chang, Susan M; Yung, WK Alfred; Drappatz, Jan; Mehta, Minesh P; Levin, Victor A; Aldape, Kenneth; Dancey, Janet E; Wright, John J; Prados, Michael D; Cloughesy, Timothy F; Gilbert, Mark R; Wen, Patrick Y